Literature DB >> 4048947

Enzymatic removal of bilirubin from blood: a potential treatment for neonatal jaundice.

A Lavin, C Sung, A M Klibanov, R Langer.   

Abstract

Current treatments for severe jaundice can result in major complications. Neonatal jaundice is caused by excessive accumulation of bilirubin in the blood. A small blood filter containing immobilized bilirubin oxidase was developed to reduce serum bilirubin concentrations. When human or rat blood was passed through the enzyme filter, more than 90 percent of the bilirubin was degraded in a single pass. This procedure may have important applications in the clinical treatment of neonatal jaundice.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4048947     DOI: 10.1126/science.4048947

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

Review 1.  Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients.

Authors:  Katsutoshi Naruse; Wei Tang; Masatoshi Makuuch
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

2.  Can we harness the microbiota to enhance the efficacy of cancer immunotherapy?

Authors:  B Brett Finlay; Romina Goldszmid; Kenya Honda; Giorgio Trinchieri; Jennifer Wargo; Laurence Zitvogel
Journal:  Nat Rev Immunol       Date:  2020-07-13       Impact factor: 53.106

Review 3.  Gut microbiome, big data and machine learning to promote precision medicine for cancer.

Authors:  Giovanni Cammarota; Gianluca Ianiro; Anna Ahern; Carmine Carbone; Andriy Temko; Marcus J Claesson; Antonio Gasbarrini; Giampaolo Tortora
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-07-09       Impact factor: 46.802

4.  Conformation of bilirubin oxidase in native and denatured states.

Authors:  T Samejima; C S Wu; K Shiboya; H Kaji; S Koikeda; K Ando; J T Yang
Journal:  J Protein Chem       Date:  1994-04

5.  Mean-field model of immobilized enzymes embedded in a grafted polymer layer.

Authors:  Yevgeny Moskovitz; Simcha Srebnik
Journal:  Biophys J       Date:  2005-04-01       Impact factor: 4.033

6.  Development and perspectives of perfusion treatment for liver failure.

Authors:  Katsutoshi Naruse; Hiroshi Nagashima; Yasuyuki Sakai; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 7.  Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin.

Authors:  Alessio Nocentini; Alessandro Bonardi; Simone Pratesi; Paola Gratteri; Carlo Dani; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

8.  Enzymatic modification of plasma low density lipoproteins in rabbits: a potential treatment for hypercholesterolemia.

Authors:  R Labeque; C J Mullon; J P Ferreira; R S Lees; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 9.  Tumour metabolism and its unique properties in prostate adenocarcinoma.

Authors:  David A Bader; Sean E McGuire
Journal:  Nat Rev Urol       Date:  2020-02-28       Impact factor: 14.432

Review 10.  Psychotropics and the Microbiome: a Chamber of Secrets….

Authors:  Sofia Cussotto; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2019-02-26       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.